CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 70 enrolled
Drug / intervention
Proton Radiationradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01340495
NCT01340495N/AUnknown
CompareCT.gov

Pilot Study of Proton Radiation Therapy for Invasive Breast Carcinoma Following Mastectomy

Massachusetts General Hospital·interventional·Posted Apr 22, 2011·Updated Jan 5, 2021

In Brief

A clinical study evaluating Proton Radiation for Invasive Breast Cancer. Targeting 70 participants across 1 site.

Detailed Summary

In this study we are looking at a type of radiation called proton radiation which is known to spare surrounding tissue and organs from radiation. The proton radiation will be delivered using 3D conformal proton radiation or scanned beam/IMPT (Intensity Modulated Proton Radiation Treatment). Proton radiation delivers no dose beyond the region requiring treatment. This may reduce side effects that patients would normally experience with conventional radiation therapy or other means of delivering proton radiation therapy. In this study we are evaluating the effectiveness of using proton radiation delivered to reduce side effects association with radiation treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInvasive Breast Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/AUnknownOverdue
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 22, 2011
Enrollment StartJun 1, 2011
Primary CompletionApr 1, 2017
Study CompletionJan 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 15.2 years ago

Interventions

Proton Radiationradiation

45-50.4 Gy(RBE) to the chest wall and 45-50.5 Gy(RBE) once daily, 5 days per week, for approximately 5 1/2 weeks